Cinnamomum Burmannii (Nees & T. Nees) Blume: A Global Evidence Review F Phytochemistry, Preclinical Pharmacology, Clinical Investigations, and Standardised Bioactive Fractions
DOI:
https://doi.org/10.46799/jhs.v7i6.2856Keywords:
Cinnamomum burmannii, cinnamon, DLBS3233, DLBS2411, cinnamaldehydeAbstract
Cinnamomum burmannii (Nees & T. Nees) Blume is one of the most widely traded cinnamon species globally and an increasingly investigated botanical source for metabolic, antimicrobial, anti-inflammatory, dermatological, and gastroprotective applications. Cultivated predominantly in Indonesia and distributed across tropical Southeast Asia and southern China, C. burmannii is distinguished by its high coumarin content, chemically rich and variable phytochemistry—dominated by cinnamaldehyde, A-type proanthocyanidins, D-borneol-rich essential oil, and phenolic acids—and by the emergence of standardized bioactive fractions with clinical development. This review integrates the totality of published evidence across two parallel research streams: a broad international body of phytochemical and pharmacological work from Indonesian, Chinese, Belgian, Portuguese, and other research groups, and a focused translational program from Dexa Laboratories of Biomolecular Sciences (DLBS), comprising DLBS3233—a combined C. burmannii/Lagerstroemia speciosa fraction supported by multiple Phase II–III randomized controlled trials in prediabetes, type 2 diabetes mellitus, and polycystic ovary syndrome—and DLBS2411, a bark-derived proton pump downregulator and mucoprotector with clinical trials in GERD, peptic ulcer, and functional dyspepsia. The collective evidence demonstrates robust antidiabetic activity via α-glucosidase inhibition, insulin receptor phosphorylation, PPARγ/GLUT4 upregulation, and TRPA1/GLP-1 stimulation; antioxidant and antilipidemic effects across multiple animal and human models; broad-spectrum antimicrobial activity against foodborne pathogens, Staphylococcus aureus, Aspergillus flavus, and Malassezia furfur, with characterized molecular mechanisms; anti-inflammatory action through NF-κB/IKK suppression; wound-healing promotion via M1 macrophage inhibition; and gastroprotective dual-mechanism activity.
References
Al-Dhubiab, B. E. (2012). Pharmaceutical applications and phytochemical profile of Cinnamomum burmannii. Pharmacognosy Reviews, 6(12), 125–131. https://pmc.ncbi.nlm.nih.gov/articles/PMC3459454/
Bahtiarsyah, A. A., Hidayati, L., Wijayanti, N., & Nuringtyas, T. R. (2023). Synergistic activity of Cinnamomum burmannii and Aquilaria malaccensis extracts for antidiabetic study. Indonesian Biomedical Journal, 15(2), 132–140.
Delfira, A., et al. (2024). The effect of cinnamon bark extract (Cinnamomum burmannii) on blood glucose levels. International Journal of Research and Review, 11(1).
Deyno, S., et al. (2019). Effect of cinnamon supplementation on lipid profiles in type 2 diabetes mellitus: A systematic review and meta-analysis. Complementary Therapies in Medicine, 46, 190–195.
Effectiveness and safety of DLBS3233 in newly diagnosed T2DM: A 12-week clinical trial. (2024). Acta Medica Indonesiana. https://actamedindones.org/index.php/ijim/article/view/2621
Full-length transcriptome combined with RNA-Seq to analyze genes related to terpenoid biosynthesis in Cinnamomum burmannii. (2022). Genes. https://pmc.ncbi.nlm.nih.gov/articles/PMC9497596/
Hayward, N. J., McDougall, G. J., et al. (2024). Effect of cinnamon spice on continuously monitored glycemic response in adults with prediabetes: A 4-week randomized controlled trial. American Journal of Clinical Nutrition. https://doi.org/10.1016/j.ajcnut.2024.01.001
Hestiantoro, A., Permadi, W., Tjandrawinata, R. R., Wiweko, B., Ritonga, M. A., et al. (2024). Efficacy and safety of DLBS3233 on endocrine-metabolic profile in PCOS: A randomized clinical trial. International Journal of Fertility & Sterility, 18(Suppl. 1), 35–47. https://pubmed.ncbi.nlm.nih.gov/39033369/
Hidayat, S. T., Mulyantoro, I., Damas, S., & Tjandrawinata, R. R. (2023). Metformin and DLBS3233 on metabolic parameters in women with PCOS. International Journal of Women's Health, 15, 971–985. https://pubmed.ncbi.nlm.nih.gov/37424700/
Hou, C., Zhang, Q., Xie, P., Lian, H., Wang, Y., Liang, D., Cai, Y., & He, B. (2023). Full-length transcriptome sequencing reveals the molecular mechanism of monoterpene and sesquiterpene biosynthesis in Cinnamomum burmannii. Frontiers in Genetics, 13, 1087495.
Jafar, N., Qalbi, F. N., et al. (2020). Effect of Cinnamomum burmannii stew on fasting blood glucose levels in adult prediabetes in Makassar. Open Access Macedonian Journal of Medical Sciences, 8(T2), 71–74.
Kumar, S., Kumari, R., & Mishra, S. (2019). Pharmacological properties and medicinal uses of Cinnamomum: A review. Journal of Pharmacy and Pharmacology, 71(12), 1735–1761. https://doi.org/10.1111/jphp.13173
Liang, H., Lv, F., Xian, M., Luo, C., Zhang, L., Yang, M., Li, Q., & Zhao, X. (2025). Inhibition mechanism of Cinnamomum burmannii leaf essential oil against Aspergillus flavus and aflatoxins. Foods, 14(4), 682. https://doi.org/10.3390/foods14040682
Ma, Q., Ma, R., Su, P., et al. (2022). Elucidation of the essential oil biosynthetic pathways in Cinnamomum burmannii through identification of six terpene synthases. Plant Science, 317, 111203. https://pubmed.ncbi.nlm.nih.gov/35193750/
Manaf, A., Tjandrawinata, R. R., & Malinda, D. (2016). Insulin sensitizer in prediabetes: A clinical study with DLBS3233. Drug Design, Development and Therapy, 10, 1279–1289. https://pubmed.ncbi.nlm.nih.gov/27099473/
Muhammad, D. R. A., Lemarcq, V., Alderweireldt, E., et al. (2020). Antioxidant activity and quality attributes of white chocolate incorporated with Cinnamomum burmannii Blume essential oil. Journal of Food Science and Technology, 57(5), 1731–1739.
Muhammad, D. R. A., Tuenter, E., Patria, G. D., Foubert, K., Pieters, L., & Dewettinck, K. (2021). Phytochemical composition and antioxidant activity of Cinnamomum burmannii Blume extracts and their potential application in white chocolate. Food Chemistry, 340, 127983. https://pubmed.ncbi.nlm.nih.gov/32919354/
Nailufar, F., & Tandrasasmita, O. M. (2011). DLBS3233 increases glucose uptake by mediating upregulation of PPARγ and PPARδ expression. Biomedical and Preventive Nutrition, 1, 71–78.
Nailufar, F., & Tjandrawinata, R. R. (2017). Evaluation of proton pump inhibitor bioactive fraction DLBS2411 in animal model of gastric ulceration healing. American Journal of Pharmacology and Toxicology, 12(4), 79–88.
Preliminary study of Cinnamomum burmannii extracts to reduce fasting blood glucose and body weight in T2DM-induced rats. (2024). Medical and Medical Journal, 5(2), 107–115.
Priani, S. E., Nurhasanah, E., & Suparman, A. (2022). Development of antiacne nanogel containing cinnamon bark oil (Cinnamomum burmannii) and olive oil. Research Journal of Pharmacy and Technology, 15(1), 143–147.
Qarani, W., Husna, F., Yulia, W., et al. (2023). Antioxidant and antiaging activities of Cinnamomum burmannii, Michelia champaca, and their combinations. Narra Journal, 3(2), e111. https://pubmed.ncbi.nlm.nih.gov/38454977/
Rahayu, D. U., Hakim, R. A., Mawarni, S. A., & Satriani, A. R. (2022). Indonesian cinnamon (Cinnamomum burmannii): Extraction, flavonoid content, antioxidant activity, and stability. Cosmetics, 9(3), 57.
Risna, R. A., et al. (2019). Optimization of water extract of Cinnamomum burmannii bark to ascertain in vitro antidiabetic and antioxidant activities. Biocatalysis and Agricultural Biotechnology, 19, 101152.
Sandhiutami, N. M. D., et al. (2023). Cinnamomum burmannii Bl. bark ameliorates lipid profile and platelet aggregation in dyslipidemia mice through antioxidant activity. Open Access Macedonian Journal of Medical Sciences, 11(A), 127–137.
Sharifi-Rad, J., Dey, A., et al. (2021). Cinnamomum species: Bridging phytochemistry, pharmacological properties and toxicological safety. Frontiers in Pharmacology, 12, 600139.
Shi, L., Lin, W., Cai, Y., Chen, F., Zhang, Q., Liang, D., Xiu, Y., Lin, S. Z., & He, B. (2024). Oxidative stress-mediated repression of virulence gene transcription and biofilm formation as antibacterial action of Cinnamomum burmannii essential oil on Staphylococcus aureus. International Journal of Molecular Sciences, 25(5), 3078. https://doi.org/10.3390/ijms25053078
Susilowati, R., & Setiawan, A. M. (2020). Cinnamomum burmannii and Eleutherine palmifolia extract combination ameliorates lipid profile and heart oxidative stress in hyperlipidemic mice. Veterinary World, 13(7), 1404–1409. https://pubmed.ncbi.nlm.nih.gov/32848317/
Susilowati, R., Setiawan, A. M., Zahroh, A. F., et al. (2022). Hepatoprotection of Cinnamomum burmannii ethanolic extract against high-fat and cholesterol diet in Sprague-Dawley rats. Veterinary World, 15(4), 930–936. https://pubmed.ncbi.nlm.nih.gov/35698494/
Tandrasasmita, O. M., Wulan, D. D., Nailufar, F., Sinambela, J., & Tjandrawinata, R. R. (2011). Glucose-lowering effect of DLBS3233 is mediated through phosphorylation of tyrosine and upregulation of PPARγ and GLUT4 expression. International Journal of General Medicine, 4, 345–357.
Tjandrawinata, R. R., Nailufar, F., & Arifin, P. F. (2013). H+/K+ATPase activity inhibition and downregulation by DLBS2411 from Cinnamomum burmannii in gastric parietal cells. International Journal of General Medicine, 6, 807–815.
Tjandrawinata, R. R., & Nailufar, F. (2020). Gastroprotective effect of DLBS2411 against ethanol-induced gastric damage in rats. Journal of Experimental Pharmacology, 12, 87–95. https://pubmed.ncbi.nlm.nih.gov/32256127/
Tjandrawinata, R. R., Suastika, K., & Nofiarny, D. (2011). DLBS3233 extract, a novel insulin sensitizer with negligible risk of hypoglycemia: A phase-I study. International Journal of Diabetes and Metabolism, 21(1), 13–20.
Tjokroprawiro, A., Murtiwi, S., & Tjandrawinata, R. R. (2016). DLBS3233 in T2DM patients inadequately controlled by metformin and other OADs. Journal of Complementary and Integrative Medicine, 13(4), 413–420.
Wang, W., Cai, S., Wang, Y., Tan, Y., Xu, J., & Xiong, P. (2025). Cinnamomum burmannii essential oil as a promising antimicrobial agent against cutaneous pathogens: Mechanistic insights into anti-Malassezia furfur activity. Microorganisms, 13(6), 1241. https://doi.org/10.3390/microorganisms13061241
Wulandari, A. S., Tandrasasmita, O. M., & Tjandrawinata, R. R. (2016). DLBS2411 as colon and gastroprotector by stimulating MUC5AC and COX-2 gene expression. International Journal of Pharmacy and Pharmaceutical Sciences, 8(8), 202–207.
Zhang, X., Lai, J., Dai, X., Huang, F., Guan, L., & Wen, R. (2025). Design and evaluation of a Cinnamomum burmannii essential oil-loaded preservative film for enhancing quality and shelf life of fish filets. Foods, 14(17), 3139. https://doi.org/10.3390/foods14173139
Zhang, X., Lin, X., Cao, J., Xie, G., Yang, X., Liu, B., Xu, X., Cheng, F., Chen, H., & Pang, Y. (2024). Application of Cinnamomum burmannii essential oil in promoting wound healing. Molecules, 29(9), 2080. https://doi.org/10.3390/molecules29092080
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Raymond R. Tjandrawinata
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under aCreative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
